An interventional study of Stimulation parameters in Chronic Pain, sponsored by Alberta Health Services, Calgary. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-08-07.
Sponsored by Alberta Health Services, Calgary · Not applicable, Interventional, and Treatment
Among 202 studies in Chronic Pain with a site in Canada — 52 open to participants now, 63 under way, 3 of them phase 3. Chronic Pain · Canada.
Among the 202 studies in Chronic Pain with a site in Canada, this one is the 130th largest by planned enrollment of the 162 interventional ones that give a count, is one of 18 that started in 2022, is one of 116 with no phase, reaches primary completion later than 31 of the 62 other live ones, and was the 123rd registered.
3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.
Browse Chronic Pain studies →52 of the 202 studies in Chronic Pain with a site in Canada are open now. Recruiting first, the newest first:
Ottawa Hospital Research Institute · Sites in Canada
Laval University · Sites in Canada
University Health Network, Toronto · Sites in Canada
University Health Network, Toronto · Sites in Canada
University of Manitoba · Sites in Canada
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
202 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 22 · Phase 3 14 · Phase 4 8
First in 2004; this study’s year is marked. 18 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 49 across the 162 interventional studies, 138 across the 40 observational. Of the 107 that completed or were terminated, 14 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
16 of 202 have an industry lead sponsor. The 10 most frequent:
Alberta Health Services, Calgary is the lead sponsor of 10 studies on the registry; 4 are open to participants now.
Alberta Health Services, Calgary has 2 studies filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
16 of the studies in Chronic Pain with a site in Canada that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05306899Phase 3University Health Network, TorontoMulti-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches | 2027-02-01 |
| NCT07137845Université de SherbrookeVirtual Reality and Cranial Nerve Non-invasive Neuromodulation to Improve Quality of Life for Veterans | 2026-12 |
| NCT06123715University Health Network, TorontoPerioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty | 2026-12-31 |
| NCT04939623University of CalgaryNovel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal | 2026-12-31 |
| NCT03675386University Health Network, TorontoReducing Opioid Use for Chronic Pain Patients Following Surgery | 2026-12-31 |
Among the 202 studies in Chronic Pain with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.
Different stimulation parameters will be tried in a blinded fashion to compare efficacy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Industry standard stimulation settings
Other: Stimulation parameters
Experimental stimulation settings
Other: Stimulation parameters
Different device stimulation parameters
Change in baseline pain measures
Pain outcomes measured using visual analogue scale
Time frame: 6 months
Effect of stimulation on quality of life
As measured using EQ-5D-3L
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2022 (actual). Primary completion is estimated for Jul 2026, 53 months after the start.
Of 1,295 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 53 months is above that.
Counting every sponsor, half of 1,378 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alberta Health Services, Calgary